JEVTANA 60 mg concentrate and solvent for solution for infusion clinical trials

A Phase 2 Trial of Nivolumab Plus Ipilimumab, Ipilimumab Alone, or Cabazitaxel in Men with Metastatic Castration-Resistant Prostate Cancer

This study looks at new drug combinations for men with advanced prostate cancer that has stopped responding to hormone therapy. It compares different treatments to see which works best at shrinking tumours and slowing cancer growth.